Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Namenda and Individualized Management in Alzheimer's Disease
NCT00120874Phase 4Completed
- Sponsor
- NYU Langone Health
- Start
- Aug 2006
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of memantine in Alzheimer's disease (AD), sponsored by NYU Langone Health. Started Aug 2006; status: completed.
02
Drugs
memantine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00120874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00120874.